← SynDRA
ML323
SynDRA canonical compound SYN0048695 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | USP1 |
|---|
| Mechanism of action | ubiquitin specific protease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- USP1 INHIBITOR
- ubiquitin specific protease inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- NR1H2
- TRIM24
- TDG
- SMUG1
- RXRA
- RORB
- OGG1
- NR5A1
- NR4A1
- NR2E1
- NR2C1
- NR1H3
- NEIL2
- AURKA
- NEIL1
- MUTYH
- MBD4
- MAPK1
- HNF4A
- GSK3B
- FGFR3
- CSNK1D
- CDK2
- BRPF1
- BRD4
- UNG
Cross-references
Synonyms
- CHEMBL3182437
- ML-323
- N-(4-(1H-1,2,3-TRIAZOL-1-YL)BENZYL)-2-(2-ISOPROPYLPHENYL)-5-METHYLPYRIMIDIN-4-AMINE
- ML 323
- RefChem:159247
- MFCD28099817
- C23H24N6
- JDA
- GTPL7898
- orb1307522
- SCHEMBL15847799
- SCHEMBL29417871
- EX-A392
- GLXC-04121
- HMS3653L13
- HMS3743A15
- BDBM50069762
- s7529
- AKOS026750196
- CCG-268461
- EBC-312054
- ML-323?
- SB19053
- NCGC00262306-01
- NCGC00262306-02
- NCGC00262306-16
- NCGC00262306-24
- NCGC00262306-25
- AC-33083
- AS-16712
- BM166458
- DA-43946
- HY-17543
- SW219291-1
- F468386
- BRD-K93942811-001-01-3
- Z2235802193
Look up ML323 in the interactive SynDRA portal →